These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34260089)
1. Complete response to pembrolizumab and radiation in a patient with HIV-negative, EBV-positive plasmablastic lymphoma. Castillo JJ; Lamacchia J; Silver J; Flynn CA; Sarosiek S Am J Hematol; 2021 Oct; 96(10):E390-E392. PubMed ID: 34260089 [No Abstract] [Full Text] [Related]
2. Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas. Kim SJ; Hyeon J; Cho I; Ko YH; Kim WS Cancer Res Treat; 2019 Apr; 51(2):611-622. PubMed ID: 30025443 [TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system plasmablastic lymphoma in an HIV-positive patient. Rhoades R; Gong J; Palmisiano N; Alpdogan O BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30872336 [TBL] [Abstract][Full Text] [Related]
4. Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient. Fukuo Y; Shibuya T; Ashizawa K; Ito K; Saeki M; Fukushima H; Takahashi M; Nomura K; Okahara K; Haga K; Akazawa Y; Nomura O; Ogura K; Okubo H; Nagahara A Intern Med; 2021 Sep; 60(18):2947-2952. PubMed ID: 33776007 [TBL] [Abstract][Full Text] [Related]
5. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis. Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211 [TBL] [Abstract][Full Text] [Related]
6. Immune profiling of a patient with relapsed HIV-Related and EBV-positive diffuse large B-Cell lymphoma treated with pembrolizumab. Korsos V; Vallée A; Rys R; Probst S; Dmitrienko S; Decaluwe H; Johnson NA Leuk Lymphoma; 2022 May; 63(5):1256-1260. PubMed ID: 34913822 [No Abstract] [Full Text] [Related]
7. Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature. Fu Z; Wang H; Lauwers GY; Jiang K; Jayaratne NL; Bridglal S; Dong N; Wang E; Chen L; Barclift DP; Zhang L Ann Diagn Pathol; 2023 Dec; 67():152204. PubMed ID: 37639839 [TBL] [Abstract][Full Text] [Related]
9. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area. Meer S; Perner Y; McAlpine ED; Willem P Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906 [TBL] [Abstract][Full Text] [Related]
10. Violaceous nodules in an HIV-positive man. Scott BL; Dominguez AR; Nguyen KD Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239893 [TBL] [Abstract][Full Text] [Related]
11. Rectal plasmablastic lymphoma in Ebstein Barr virus positive and human immunodeficiency virus negative subject after external radiation therapy for prostatic cancer. Bricman L; Yengue P; Miscu C; Junius S; Waignein F; Vandenbulcke JM Acta Gastroenterol Belg; 2021; 84(4):663-665. PubMed ID: 34965049 [TBL] [Abstract][Full Text] [Related]
12. Relapse of Plasmablastic Lymphoma With Cutaneous Involvement in an Immunocompetent Male. Shwe S; Sharma AA; Lee BA; Smith JE Ear Nose Throat J; 2022 Jun; 101(5):NP222-NP225. PubMed ID: 32955361 [TBL] [Abstract][Full Text] [Related]
13. EBV positive mucocutaneous ulcer with plasmacytic/plasmablastic differentiation and MYC rearrangement: a diagnostic challenge and a mimic of plasmablastic lymphoma. Chen BJ; Chiang WF; Chen TS; Kao HJ; Chuang SS Pathology; 2019 Oct; 51(6):648-650. PubMed ID: 31472984 [No Abstract] [Full Text] [Related]
14. Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use. Vaughan J; Perner Y; Mayne E; Wiggill T HIV Med; 2021 Mar; 22(3):225-230. PubMed ID: 33022825 [TBL] [Abstract][Full Text] [Related]
16. PD-L1 Antibodies for EBV-Positive Gastric Cancer, Going Beyond PD-L1 Expression and Microsatellite Instability. Almhanna K; Antonia S J Natl Cancer Inst; 2018 Mar; 110(3):221-222. PubMed ID: 29155933 [No Abstract] [Full Text] [Related]
17. Fistulizing Epstein-Barr virus-positive plasmablastic lymphoma in an HIV-positive man. Rangel J; Novoa R; Morrison C; Frank D; Kovarik C Br J Dermatol; 2016 Feb; 174(2):398-401. PubMed ID: 26286218 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report. Lai J; Xu P; Jiang X; Zhou S; Liu A BMC Cancer; 2017 Jul; 17(1):507. PubMed ID: 28754096 [TBL] [Abstract][Full Text] [Related]
19. Atypical presentation of plasmablastic lymphoma in immunocompetent patient. Khan MD; Natarajan S; Lekharaju V BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848405 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases. Liu M; Liu B; Liu B; Wang Q; Ding L; Xia C; Dong L Oncol Rep; 2015 Apr; 33(4):1615-20. PubMed ID: 25695332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]